Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice
- PMID: 33675873
- DOI: 10.1016/j.jhep.2021.02.026
Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice
Conflict of interest statement
Conflict of interest The authors declare no competing interests. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice".J Hepatol. 2021 Jul;75(1):241-243. doi: 10.1016/j.jhep.2021.04.014. Epub 2021 Apr 20. J Hepatol. 2021. PMID: 33892005 No abstract available.
Comment on
-
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.J Hepatol. 2019 Oct;71(4):719-730. doi: 10.1016/j.jhep.2019.05.029. Epub 2019 Jun 13. J Hepatol. 2019. PMID: 31201834 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
